Literature DB >> 27734455

Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.

Mateusz Tajstra, Elżbieta Gadula-Gacek1, Anna Kurek, Elżbieta Adamowicz-Czoch, Dawid Olszowski, Mateusz Ostręga, Aneta Ciślak, Łukasz Pyka, Michał Hawranek, Andrzej Lekston, Lech Poloński, Mariusz Gąsior.   

Abstract

BACKGROUND: Current real-life information from all-comers registries from middle and east Europe about the incidence and type of complications during long-term follow-up of patients with cardioverters-defibrillators (ICD) and cardiac resynchronization devices-defibrillators (CRT-D) is still insufficient. The aim of the study was to assess the incidence and determinants of short- and long-term complications related to implantable ICD and CRT-D.
METHODS: We studied 1,105 recipients hospitalized in our center in 2009-2013, followed for a mean of 2.4 years (total of 2,652 patient-years). The independent association between ICD and CRT-D recipients' and implantation-procedures' characteristics with the incidence of complications was analyzed using multivariable Cox regression analysis.
RESULTS: In 2-month post-procedural period, 124 (11.2%) patients developed complications. Independent predictors of short-term complications (within 2 months) were: atrial fibrillation, dual chamber ICD implantation, and use of antiplatelet therapy or coumarin. Twenty-seven (2.44%) patients experienced complications, mostly lead-related (n = 21). Independent predictors of long-term complications (2-12 months after implantation) were atrial fibrillation and dual chamber ICD implantation.
CONCLUSIONS: Despite significant technological progress and operators' experience, the occurrence of complications in ICD and CRT-D recipients is still substantial. Majority of complications are recorded in the early post-implantation phase. Analysis of independent predictors of complications seem to be essential in helping to reduce adverse events in the future and strongly supports the need for routine follow-up.

Entities:  

Keywords:  cardiac electronic implantable devices; cardiac resynchronization therapy; cardioverter-defibrillator; complications; registry

Mesh:

Year:  2016        PMID: 27734455     DOI: 10.5603/CJ.a2016.0092

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  2 in total

1.  Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry.

Authors:  Sandro Brusich; Ivan Zeljković; Nikola Pavlovic; Ante Anić; Zrinka Jurišić; David Židan; Marina Klasan; Zlatko Čubranić; Kenneth Dickstein; Cecilia Linde; Camilla Normand; Sime Manola
Journal:  Cardiol Res Pract       Date:  2018-10-25       Impact factor: 1.866

2.  Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up.

Authors:  Stefan Warpechowski Neto; Laura Lessa Gaudie Ley; Eduardo Dytz Almeida; Marco Aurélio Lumertz Saffi; Luiza Zwan Dutra; Antonio Lessa Gaudie Ley; Roberto Tofani Sant'Anna; Gustavo Glotz de Lima; Renato Abdala Karam Kalil; Tiago Luiz Luz Leiria
Journal:  Arq Bras Cardiol       Date:  2019-02-21       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.